The Gail Parkins Memorial Ovarian Cancer Walk & 5K Run celebrated their 20th anniversary this year; raising $250,000 for ovarian cancer research at Duke.
Five questions for gynecologic oncologist Brittany Davidson, MD, about the best approach to patient goals and treatment expectations in terminal ovarian cancer
DCI medical oncologists Angeles Alvarez Secord, MD, MHSc, and Rafael Gonzalez, MD, & genetics counselor Maggie Frazier, MS, CGC discussed ovarian cancer, in this DCI OHE event for the community.
Four-year ovarian cancer survivor Kathy Jennings says that attending the annual Gail Parkins Memorial Ovarian Cancer Walk and 5K Run each year feels like coming home.
Gynecologic oncologist Angeles Alvarez Secord, MD, MHS, weighs in on screening & symptoms in ovarian cancer. September is National Ovarian Cancer Awareness Month.
Ready, set, register for the Virtual Gail Parkins Memorial Ovarian Cancer Walk & 5K Run. Educational Symposium (9.26) features doctors Berchuck and Secord.
ICYMI the AACI's Physician Clinical Leadership Initiative (PCLI) presented a two-part webinar series on hereditary cancer programs and cancer risk assessment.
The fundraiser, which supports Duke research, has been held each year since 2002 in memory of Gail Parkins. The annual event saw its biggest ever turnout of survivors.
The 17th annual Gail Parkins Memorial Ovarian Cancer Walk & 5K Run will take placeSaturday, Sept. 21, 2019 at Sanderson High School in Raleigh, North Carolina.
In about half of all surgeries performed each day at Duke, a real-time pathological analysis may be performed on a “frozen section” of tissue before the patient wakes up.
Survivors, family members, and researchers have been working together for more than a decade to detect ovarian cancer earlier and educate women about its signs.
Melanie Bacheler worked full time, coached gymnastics part-time, and was a new mom of a six-month-old when her mother was diagnosed with stage 3 ovarian cancer.
The 2017 Gail Parkins Memorial Ovarian Cancer Walk and 5K Run will take place Saturday, Sept. 16, at Sanderson High School, located at 5500 Dixon Driv...
When Julie Cardillo was diagnosed with cancer she turned to a soothing sanctuary where for most of her lifetime she has best been able to express the ...
A group of Duke Cancer Institute gynecologic oncology researchers has published a new paper this month with their projections on the cost-effectivenes...
When IBM IT architect Laura Elzie, 60, was first diagnosed with ovarian cancer three years ago by her long-time primary care physician she was momenta...
Rebecca Previs, MD, has been selected as a recipient of a 2019 American Association of Obstetricians and Gynecologists Foundation (AAOGF) and GOG Foun...
Mutations in the BRCA gene correspond to a higher lifetime risk of developing breast and ovarian cancers, and many women who carry these mutations con...
It’s been called the silent killer because it spreads fairly quietly, before causing painful symptoms. By the time many women are diagnosed with ovari...
On Thursday, May 22, Andrew Berchuck, MD, director of Gynecologic Oncology, sat down with Bob Buckley, WGHP-TV, to discuss an international research c...
The 15th annual Gail Parkins Memorial Ovarian Cancer Walk and 5K Run, held on Saturday, Sept. 16, in Raleigh, raised more than $250,000 this year for ...
A genetic examination of the DNA of almost 100,00 people, including 17,000 patients with the most common type of ovarian cancer, has identified 12 new...
Kris Wood, PhD, assistant professor of Pharmacology and Cancer Biology, has been named to receive the 2015 Liz Tilberis Early Career Award from the Ov...
A group of Duke Cancer Institute gynecologic oncologists, led by Andrew Berchuck, MD, are advising, in a perspectives article in the Journal of Clinic...
Women who carry the BRCA1 gene mutation that dramatically increases their risk of breast and ovarian cancers are also at higher risk for a lethal form...